Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global active pharmaceutical ingredient market to reach USD 213.84 billion in 2021 and is growing at a CAGR of 6.3% during 2016-2021

02-Aug-2016 | Number of pages: 110 | Report Code: ZMR-56 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the active pharmaceutical ingredient market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the active pharmaceutical ingredient along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active pharmaceutical ingredient market on a global level.

In order to give the users of this report a comprehensive view on the active pharmaceutical ingredient market, we have included a detailed segmentation of active pharmaceutical ingredient. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the active pharmaceutical ingredient market has also been included. The study encompasses a market attractiveness analysis, wherein type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the active pharmaceutical ingredient market by segmenting the market based on API synthesis, biotech API, synthetic chemical API and HPAPI. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The active pharmaceutical ingredient market’s manufacturing type segment includes contract manufacturing and in-house API manufacturing. The drug type segment includes branded drugs, generic drugs, and OTC drugs. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific and Rest of the world. This segmentation includes demand for active pharmaceutical ingredient based on individual applications in all the regions.

The key players active in this market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others.

The report segments the global active pharmaceutical ingredient market as

Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis

  • Biotech API
  • Synthetic Chemical API
  • HPAPI

Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis

  • Contract Manufacturing
  • In-House API Manufacturing

Active Pharmaceutical Ingredient Market: Type of API Segment Analysis

  • Synthetic API
  • Biological API

Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis

  • Branded Drugs
  • Generic Drugs
  • OTC Drugs

Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis

  • Cardiology
  • Oncology
  • Anti-Inflammatory
  • Gastrointestinal 
  • Other

Related Reports

Upper Respiratory Tract Treatment Infection Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1720 | Report Format:

Global Upper Respiratory Tract Treatment Infection Market: Overview One of the most common reasons for the people visiting the clinics and hospitals is upper respiratory tract infection. A contagious and acute infection that occurs in the upper respiratory tract is known as upper respiratory tra...Read More

Sickle Cell Anemia Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1712 | Report Format:

Global Sickle Cell Anemia Treatment Market: Overview A disorder of the red blood cells is sickle cell anemia. This is an inherited disease. In this disease the red blood cells have a short life thus healthy cells are scarce for transporting adequate amount of oxygen to the organs. In normal cond...Read More

Tuberculosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1702 | Report Format:

Global Tuberculosis Therapeutics Market: Overview Mycobacterium tuberculosis is the bacteria that cause the chronic infectious disease tuberculosis. Pulmonary tuberculosis is the alternate name for tuberculosis. In this disease, the bacteria majorly infects any part of the body, mainly it is the...Read More

Systemic Infection Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1701 | Report Format:

Global Systemic Infection Treatment Market: Overview Systemic infection is a pathogenic infection that gets affected throughout the body. It can consist of viral, bacterial, or fungal infections. Systemic infection affects the persons bloodstream and gradually spreads to the whole body. The syst...Read More

Empty Capsules Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1694 | Report Format:

Global Empty Capsules Market: Overview Empty capsules allow users to fill colorants, bulking agents, and fillers on their own in the capsule. It also permits the user to mix different ingredients together and accordingly decide the specifications of the capsules. Empty capsules are safe, cheaper...Read More

Choose License Type: